nivolumab,cabozantinib,ipilimumab
bms
['opdivo', 'yervoy', 'cabometyx', 'renal,(-adrenal)']
cabometyx plus opdivo and yervoy is promising for patients with renal cell carcinoma with variant histologies, recent research presented at #asco23 showed. #kidneycancer 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.